Paper Titles in Periodical
International Letters of Chemistry, Physics and Astronomy
Volume 47

Subscribe

Subscribe to our Newsletter and get informed about new publication regulary and special discounts for subscribers!

ILCPA > Volume 47 > Synthesis and Biological Screening of...
Synthesis and Biological Screening of 3-Aryl-5-[(4′-Difluoromethoxy)(3′-Hydroxy)Phenyl]-4,5-Dihydro Isoxazole
< Back to Volume

Synthesis and Biological Screening of 3-Aryl-5-[(4′-Difluoromethoxy)(3′-Hydroxy)Phenyl]-4,5-Dihydro Isoxazole

Full Text PDF

Abstract:

Isoxazoline derivatives shows various types of therapeutic activities like antimicrobial[1], anti-inflammatory[2], anticonvulsant[3], Hypoglycemic[4] etc. getting to synthesized in view of 3-Aryl-5-[(4′-difluoromethoxy)(3′-hydroxy)phenyl]-4,5-dihydro isoxazole (4a-4i) have been synthesized. All the newly synthesized compounds were screened for their antibacterial activity against S. aureus, M. luteus (Gram-positive bacteria), E. coli, S. thyphi (Gram-negative bacteria) and antifungal activity against Candida albicans (Fungi). The biological activities (MIC) of the synthesized compounds were compared with known standard drugs.

Info:

Periodical:
International Letters of Chemistry, Physics and Astronomy (Volume 47)
Pages:
133-138
DOI:
https://doi.org/10.18052/www.scipress.com/ILCPA.47.133
Citation:
V.N. Bhadani et al., "Synthesis and Biological Screening of 3-Aryl-5-[(4′-Difluoromethoxy)(3′-Hydroxy)Phenyl]-4,5-Dihydro Isoxazole", International Letters of Chemistry, Physics and Astronomy, Vol. 47, pp. 133-138, 2015
Online since:
February 2015
Authors:
V.N. Bhadani, H.D. Purohit, Dipak M. Purohit
Keywords:
Antibacterial Activity, Antifungal Activity, Isoxazole
Export:
RIS, BibTeX, Text
Distribution:
Open Access

Creative Commons License
This work is licensed under a
Creative Commons Attribution 4.0 International License

References:

K Tomita, Y Takahi and H Vdaira ; Ann. Sankyo Res. Lab., 1973 1, 25.

PT Gallagher, TA Hicka and GW Mullier ; Eur. Pat. Ep., 1988, 2(57), 882 ; Chem. Abstr., 1988, 108, 6499K.

TU Quazi ; Pak. J. Sci. Ind. Res., 1984, 27, 326; Chem. Abstr., 1985, 103, 12339m.

Nippon Chemiphar Co. Ltd.; Jpn. Kokai Koho JP, 1983, 58, 46, 077 (Cl. CO7A 261/14).

A Ando and RW Stevens ; PCT Int. Appl. WO, 94(12), 481 (Cl. C07 D 261/04).

W Wells, A Michele, H Todd, H Dennis ; US Pat. Appl. Publ. US, 2002, 49(213), (Cl. 514-252, 05; C07D413/02).

A Shehata and RA Glannoh ; J. Het. Chem., 1987, 24, 1291. Compounds Id Antibacterial Activity Antifungal Activity Gram-positive bacteria Gram-negative bacteria S. aureus M. luteus E. coli S. aureus M. luteus 4a 80 80 160 160 160 4b 80 80 160 80 160 4c 160 80 80 40 40 4d 40 80 40 40 40 4e 40 80 40 40 40 4f 160 80 80 160 160 4g 80 40 80 40 80 4j 80 160 160 160 160 4i 40 80 80 40 40 Ampicillin 20 20 40 20 - Fluconazole - - - - 10.

R Major, B Eisele, P Mutler and H Grube ; Ger. Offen. DE, 1988, 3621372; Chem. Abstr., 1988, 108, 67456r.

C. P. Alfred, C. David Herman, D. Nancy, B. Daniel ; PCT Int. Appl. WO, 1995, 95(22), 9103 ; Chem. Abstr., 1996, 124, 3055m.

M Tibor, PS Neil and SP Henry, Gount ; PCT Int. Appl. WO 9414, 782 (Cl. C 07D 261/08).

I Masatoshi, T Akie, G Kyoto ; Jpn. Kokai Tokkyo Koho JP, 1995, 07(215), 952.

Clause, G. W. Understanding Microbes: A Laboratory Textbook for Microbiology, W.H. Freeman and Company, New York, USA, (1989).

National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobial disk susceptibility test, NCCLS, Villanova, PA, 1997. ( Received 07 February 2015; accepted 21 February 2015 ).

Show More Hide